Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/05/1991 | CA2040862A1 Spray granules or microgranules of pure riboflavin which contain no binder, are non-dusting and free flowing, and the preparation thereof |
11/05/1991 | CA1291766C Pharmaceutical compositions for the therapy of cerebropatheis on functional and organic base |
11/05/1991 | CA1291765C Antimicrobial agents and process for their manufacture |
11/05/1991 | CA1291758C Derivatives of 3-imino-pyridazine, process for obtaining them and pharmaceutical compositions containing them |
11/05/1991 | CA1291757C Pyrimidine derivatives |
11/05/1991 | CA1291754C Fused five-ring heterocyclic compounds, their production, and their pharmaceutical use |
11/05/1991 | CA1291748C .beta.-LACTAM ANTIBIOTICS |
11/05/1991 | CA1291710C Tetrapyrrole therapeutic agents |
11/05/1991 | CA1291709C Peptic ulcer treatment method |
11/04/1991 | WO1991016895A1 Pharmaceutical composition |
11/04/1991 | CA2041703A1 Flavor enhancing and increasing efficacy of cough drops |
11/04/1991 | CA2041702A1 Flavor enhancing and medicinal taste masking agent |
11/03/1991 | WO1991016894A1 Quinolizinone type compounds |
11/03/1991 | CA2040996A1 Composition and method for controlling cholesterol |
11/02/1991 | WO1991017266A1 Identification of novel drugs and reagents |
11/02/1991 | WO1991017149A1 3-naphthyl-3-carboxyalkylthio or oxy substituted alkanoic acid leukotriene antagonists |
11/02/1991 | WO1991016889A1 Five-membered ring alkanoic acid leukotriene antagonists |
11/02/1991 | WO1991016887A1 Biodegradable polyesters for sustained drug delivery |
11/02/1991 | CA2081984A1 Identification of novel oligonucleotide drugs and reagents using combinational vector libraries |
11/02/1991 | CA2081897A1 Biodegradable polyesters for sustained drug delivery |
11/02/1991 | CA2081480A1 3-naphthyl-3-carboxyalkylthio or oxy substituted alkanoic acid leukotriene antagonists |
11/02/1991 | CA2081462A1 Five-membered ring alkanoic acid leukotriene antagonists |
10/31/1991 | WO1991016902A1 Inhibition of influenza virus replication by oligonucleotides |
10/31/1991 | WO1991016901A1 Oligonucleotide modulation of arachidonic acid metabolism |
10/31/1991 | WO1991016355A1 Method for increasing blood-brain barrier permeability |
10/31/1991 | WO1991016330A1 Amethopterin(methotrexate) pro-drugs, intermediate products, a preparation method, and compositions containing them |
10/31/1991 | WO1991016327A1 Antimicrobial quinolonyl lactams |
10/31/1991 | WO1991016324A1 Novel cc-1065 analogs |
10/31/1991 | WO1991016315A1 5-benzyl barbiturate derivatives |
10/31/1991 | WO1991016310A1 Antimicrobial quinolone thioureas |
10/31/1991 | WO1991016307A1 3-indolyl thioacetate derivatives |
10/31/1991 | WO1991016303A1 Cyclic hydroxamic acids and their use |
10/31/1991 | WO1991016302A1 Phenolic amine depigmenting and antimelanoma agents |
10/31/1991 | WO1991016075A1 Bone marrow treatments |
10/31/1991 | WO1991016056A1 Use of purinergic receptor agonists as antineoplastic agents |
10/31/1991 | WO1991016055A1 2(5h)-furanones substituted in the 5 and or in the 4 position, as anti-inflammatory agents |
10/31/1991 | WO1991016054A1 Azo-derivatives, pharmaceutical preparations containing them, and their use against aids |
10/31/1991 | WO1991016053A1 The use of synthetic metalloporphyrins in the treatment of hypertension and other vascular disorders |
10/31/1991 | WO1991016051A1 Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit egf receptor tyrosine kinase |
10/31/1991 | WO1991016050A1 Veterinary treatment |
10/31/1991 | WO1991016048A1 2(5H)-FURANONES SUBSTITUTED IN THE 3 POSITION, AS Ca2+ CHANNEL ANTAGONISTS AND ANTI-INFLAMMATORY AGENTS |
10/31/1991 | WO1991016046A1 Use of acetoacetyl carboxylic acid derivatives for immunosuppression |
10/31/1991 | WO1991016045A2 Use of 5-ht4 receptor antagonists in the treatment of arrythmias and stroke |
10/31/1991 | WO1991016042A1 Controlled release drug formulation |
10/31/1991 | WO1991016031A1 Psoriasis treatment |
10/31/1991 | WO1991016024A1 Cationic lipids for intracellular delivery of biologically active molecules |
10/31/1991 | WO1991016021A1 Treatment of erectile dysfunction |
10/31/1991 | WO1991013055A3 New aryl- and heteroarylethenylene derivatives and process for their preparation |
10/31/1991 | WO1991009961A3 Novel products |
10/31/1991 | CA2081777A1 Inhibition of influenza virus replication by oligonucleotides |
10/31/1991 | CA2081769A1 Oligonucleotide modulation of arachidonic acid metabolism |
10/31/1991 | CA2081308A1 Method for increasing blood-brain barrier permeability |
10/31/1991 | CA2080581A1 Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit egf receptor tyrosine kinase |
10/31/1991 | CA2078771A1 2(5h)-furanones substituted in the 5 and or in the 4 position, as anti-inflammatory agents |
10/31/1991 | CA2078444A1 Antimicrobial quinolonyl lactams |
10/31/1991 | CA2077435A1 Novel antimicrobial quinolone thioureas |
10/31/1991 | CA2062715A1 Saccharide compositions, methods and apparatus for their synthesis |
10/31/1991 | CA2041462A1 Ethanobicyclic amine derivatives for cns disorders |
10/31/1991 | CA2040551A1 Deoxymacrolide derivatives having immunosuppressive activity |
10/31/1991 | CA2039763A1 Combination of pravastatin and a fibric acid derivative, and method for treating dyslipidemia using such combination |
10/30/1991 | EP0454651A2 Novel platelet-aggregation inhibitors |
10/30/1991 | EP0454617A1 Treatment of sinus headache |
10/30/1991 | EP0454587A1 Heterocyclic derivatives: 2-styryl-4H-1-benzopyran-4-ons, process for their preparation and pharmaceutical compositions containing them |
10/30/1991 | EP0454580A2 Novel nojirimycin derivatives |
10/30/1991 | EP0454511A1 N-substituted heterocycle derivatives, their preparation, compositions containing them |
10/30/1991 | EP0454498A2 Pyrimidinedione derivatives and antiarrhythmic agents containing same |
10/30/1991 | EP0454494A2 Calicheamicinone, derivatives and analogs thereof and methods of making the same |
10/30/1991 | EP0454469A1 Carboxylic acid derivatives |
10/30/1991 | EP0454449A1 Carboxylic acid derivatives |
10/30/1991 | EP0454441A1 Antimicrobial compositions and process for preparing the same |
10/30/1991 | EP0454436A1 Pharmaceutical compounds |
10/30/1991 | EP0454429A2 Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases |
10/30/1991 | EP0454427A1 Antiretroviral bases |
10/30/1991 | EP0454396A1 Tablet composition and method for problem pharmaceutical materials |
10/30/1991 | EP0454146A1 Cytotoxic bicyclo[7.3.1] tridec-4-ene-2,6-diyne compounds and process for the preparation thereof |
10/30/1991 | EP0454127A1 Hardening agent for affected tissues of digestive system |
10/30/1991 | EP0454121A2 Azatetracyclic compounds |
10/30/1991 | EP0454102A2 Essential fatty acid compositions |
10/30/1991 | EP0454089A1 Percutaneously absorbable eperisone or tolperisone preparation |
10/30/1991 | EP0454060A1 3-(Mercaptoalkyl)-quinazoline-2,4(1H,3H)-diones, processes for their preparation, and pharmaceutical compositions |
10/30/1991 | EP0454058A2 Use of anthraquinone derivatives in the prophylaxis and treatment of viral diseases |
10/30/1991 | EP0453960A1 Sulfonylamino substituted bicyclyl hydroxamic acid derivatives |
10/30/1991 | EP0453952A2 A process for synthesizing cephalosporin compounds |
10/30/1991 | EP0453924A1 A process for synthesizing cephalosporin compounds |
10/30/1991 | EP0453841A2 Process for the preparation of esters of 1-alcoxyhexatriene-2-carboxylic acid |
10/30/1991 | EP0453692A1 Novel nojirimycin derivatives |
10/30/1991 | EP0453658A2 Use of substituted anilides and sulfonamides in the treatment of cardiovascular diseases |
10/30/1991 | EP0453603A1 Piroxicam containing pharmaceutical compositions for topical application |
10/30/1991 | EP0453515A1 Composition for treatment of senile dementia |
10/30/1991 | EP0453507A1 Chelating agent derivatives |
10/30/1991 | EP0453497A1 Treatment methods and vaccines |
10/30/1991 | EP0438519A4 Therapeutic peptides |
10/30/1991 | EP0417104A4 Perfluorochemical emulsion with stabilized vesicles |
10/30/1991 | EP0358719B1 Liposome compositions of anthracycline derivatives |
10/30/1991 | EP0179808B1 Pharmaceutical composition suitable for treatment or prophylaxis of cardiac disorders |
10/30/1991 | CN1055819A Pharmaceutical containing episialo complex carbohydrate |
10/30/1991 | CN1055741A Ganglioside derivatives |
10/30/1991 | CN1055740A Difluoroglutamic acid conjugates with folates and anti-folates for treatment of neoplastic disease |
10/30/1991 | CN1055739A Hemihydrate |
10/30/1991 | CN1055735A Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same |